Maz Ganat, MD

  • Urologic Oncology
  • Urology

I am dedicated to providing you the best care possible and helping you choose the best treatment that is right for you. I look forward to meeting you and thank you for choosing me as your doctor.

Specialties, Procedures &
Conditions Treated

Primary Areas of Practice

  • Urologic Oncology
  • Urology

Other Areas of Practice

  • Bloodless Medicine

Procedures

  • Adrenalectomy
  • Circumcision
  • Cystectomy
  • Cystoscopy
  • Endoscopic Surgery
  • Kidney-Sparing Surgery
  • Lithotripsy
  • Minimally Invasive Surgery
  • MRI/Ultrasound Fusion Prostate Biopsy
  • Nephrectomy
  • Nephrectomy, Laparoscopic
  • Nephrectomy, Robotic
  • Nephrolithotomy
  • Orchiectomy
  • Partial Cystectomy
  • Partial Nephrectomy
  • Percutaneous Transurethral Resection
  • Pyeloplasty
  • Robotic Prostatectomy
  • Robotic Surgery
  • Uretoscopy (With or Without Biopsy)

Conditions Treated

  • Adrenal Cancer
  • Benign Prostatic Hyperplasia (BPH)
  • Bladder Cancer
  • Enlarged Prostate
  • Erectile Dysfunction
  • Hematuria
  • Kidney Cancer
  • Kidney Stones
  • Prostate Cancer
  • Prostate Disorders
  • Prostatitis
  • Renal Cancer
  • Testicular Cancer
  • Urologic Cancer
  • Urologic Disorders

Locations &
Appointments

Locations

  • Englewood Health Physician Network Urology

    350 Engle Street Suite 6530 Englewood, NJ 07631

    Main: 201-608-2849
    Fax: 201-608-2772

    Monday
    8:00 AM
    -
    5:00 PM
  • Englewood Health Physician Network Urology

    22-18 Broadway Suite 301 Fair Lawn, NJ 07410

    Main: 973-321-2755
    Fax: 973-321-2750

    Tuesday
    9:00 AM
    -
    12:00 PM

    Dr. Ganat sees patients in Fair Lawn on the first Tuesday of each month.

Insurance

Insurances Accepted

Below is a list of the insurance plans that your provider participates in. It is very important that you contact your insurance company prior to receiving services or care. Each health insurance plan is different and some provide different levels of coverage: only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.

1199 (SEIU)

  • 1199 (SEIU)

Aetna

  • Aetna HMO
  • Aetna Medicare Managed Care
  • Aetna POS
  • Aetna PPO
  • Medsolutions
  • Meritan Health

Amerigroup

  • Amerigroup Medicaid
  • Amerivantage

AmeriHealth

  • AmeriHealth Administrator
  • AmeriHealth HMO
  • AmeriHealth PPO
  • Value Network (Exchange Plan)

APWU

  • APWU Health Plan

Cigna

  • Cigna HMO
  • Cigna PPO
  • Cigna Supplemental
  • Great-West Healthcare (GWH)
  • Health Partners

Clover Health

  • Clover Health

CoreSource

  • CoreSource

Coventry

  • CCN

EmblemHealth

  • EmblemHealth EPO
  • EmblemHealth EPO2
  • EmblemHealth FEHB
  • EmblemHealth FEHBP
  • EmblemHealth GHI CBP
  • EmblemHealth GHI PPO
  • EmblemHealth National
  • EmblemHealth PPO1
  • EmblemHealth PPO2
  • EmblemHealth PPO3
  • EmblemHealth Tri-State
  • Vytra

Empire BCBS

  • Blue Access Network
  • Blue Priority
  • Direct HMO
  • Direct PPO
  • Empire BCBS EPO
  • Empire BCBS HMO
  • Empire BCBS POS
  • Empire BCBS PPO
  • Pathway EPO
  • Pathway HMO
  • Prism
  • Silver
  • Total Blue

Empire Plan (NYSHIP)

  • Empire Plan (NYSHIP)

First Health

  • First Health

GEHA

  • GEHA Health Plan

Horizon BCBS

  • Federal Employee Program
  • Horizon BCBS EPO
  • Horizon BCBS HMO
  • Horizon BCBS Medicare Managed Care
  • Horizon BCBS PPO
  • NJ Carpenters Fund
  • OMNIA Tier 1
  • Traditional

Horizon NJ Health

  • Horizon NJ Health Medicaid

MagnaCare

  • Local 825
  • MagnaCare PPO

Mail Handlers

  • Mail Handlers Benefit Plan (MHBP)

Medicaid

  • Medicaid NJ

Medicare

  • Medicare NJ

MultiPlan/PHCS

  • Beech Street
  • MultiPlan Humana
  • MultiPlan Worker's Comp
  • PHCS
  • Pomco

MVP Health Care

  • MVP Health Care PPO

NALC

  • NALC Health Benefit Plan

Nippon Life Insurance Co of America

  • Nippon Life Benefits

Oxford

  • Freedom
  • Garden State Network
  • Liberty
  • Metro
  • Oxford Medicare

QualCare

  • Choice Care
  • HIP HMO
  • HIP PPO
  • HIP PRIME HMO
  • HIP PRIME PPO
  • Oscar
  • QualCare EPO
  • QualCare FEHB
  • QualCare GHI PPO
  • QualCare HMO
  • QualCare Humana
  • QualCare PPO
  • QualCare Worker's Comp

Railroad Medicare

  • Railroad Medicare NJ

TRICARE North Region

  • CHAMPVA
  • DVA

UMR

  • UMR

United Healthcare Community and State

  • Dual Complete
  • United Healthcare Community and State Medicaid (NJ Family Care)
  • United Healthcare Community and State Medicare

UnitedHealthcare

  • AARP
  • Commercial and Marketplace
  • Compass Benefit (Exchange)
  • Medica
  • River Valley
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare StudentResources

Wellcare

  • Wellcare Medicaid Managed Care
  • Wellcare Medicare Managed Care

About

About Maz Ganat

Dr. Ganat, Program Director of Urologic Oncology at Englewood Hospital, specializes in cancers of the prostate, bladder, kidney, testis, and penis and performs both open and robotic surgeries. He obtained his MD from SUNY Downstate College of Medicine and did his internship in surgery and residency in urology at SUNY Downstate Medical Center. Following his residency, Dr. Ganat completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a member of the American Urological Association and the Society of Urologic Oncology. Dr. Ganat's research interests are the immunogenomics of urologic malignancies and precision medicine.

Honors & Awards

2020, 2019: Bergen Magazine Top Doctors

Arnold P. Gold Foundation Humanism Award

Professional Memberships

American Urological Association

Society of Urologic Oncology

Education &
Training

Education & Degrees

MD: SUNY Downstate College of Medicine

Residency

SUNY Downstate Medical Center

Fellowship

Memorial Sloan Kettering Cancer Center, Urologic Oncology

Publications

Publications

Gatto F, Blum KA, Hosseini SS, Ghanaat M, Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, andNielsen J. Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cellcarcinoma. Accepted to European Urology Oncology. May 2018

Mendonca S, Sanchez A, Blum K, Ghanaat M, Kashan M, Becerra M, Manley B, Benfante N, Russo P, Coleman J,Crago A, Hakimi AA The Association of Renal Cell Carcinoma with Gastrointestinal Stromal Tumors. The Journal ofSurgical Oncology. Accepted March, 2018 In Press

Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra M, Manley BJ, Casuscelli J,Chiok M, Tikoo S, Akin O, Coleman JA, Russo P, Hakimi AA. Cystic renal cell carcinoma: a report on outcomes ofsurgery and active surveillance in patients retrospectively identified on pretreatment imaging. The Journal of Urology. 2018 Feb 26.

Comparison of Postoperative Ileus Rates Using GIA-80 versus GIA-60 Intestinal Stapler Device after RadicalCystectomy. Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Dalbagni G, HerrHW, Bochner BH, Vickers AJ, and Donat SM. Submitted.

Characterizing Recurrent and Lethal Small Renal Masses in Clear Cell Renal Cell Carcinoma Using Recurrent SomaticMutations.Manley BJ, Reznik E, Ghanaat M, Kashan M, Becerra MF, Casuscelli J, Tennenbaum D, Redzematovic A, Carlo MI,Sato Y, Arcila ME, Voss MH, Feldman DR, Motzer RJ, Russo P, Coleman J, Hsieh JJ, Hakimi AA. Urologic Oncology:Seminars and Original Investigations 2017 Nov 11. Elsevier.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. Becerra MF,Reznik E, Redzematovic A, Tennenbaum DM, Ghanaat M, Kashan M, Casuscelli J, Manley BJ, Arcila ME, Carlo MI,Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, and Hsieh JJ. EuropeanUrology Focus. 2017 Oct 20.7. Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma.Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic D, Arcila ME, Tennenbaum DM, GhanaatM, Kashan M, Stief CG, Carlo MI, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, HsiehJJ, Hakimi AA. European Urology Focus. 2017 Sep 23.

Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Winer AG,Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD, Sankin AI, Sfakianos JP, Cha EK, Dalbagni G, ColemanJA. In Urologic Oncology: Seminars and Original Investigations 2017 Apr 30 (Vol. 35, No. 4, pp. 151-e9). Elsevier.

Secondary pelvic congestion syndrome: description and radiographic diagnosis. Winer AG, Chakiryan NH, MooneyRP, Verges D, Ghanaat M, Allaei A, Robinson L, Zinn H, Lang EK. The Canadian Journal of Urology. 2014Aug;21(4):7365-8.